Atlas Trials

Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer

Clinical trial NCT07458204 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07458204
Sponsor
Institut Jean-Godinot
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Triple-negative Breast Cancer
Start date
2026-10-01
Primary completion
2031-10-01
Enrollment
760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.